We read with interest the report of the superiority placebo-controlled trial by Bolt et al,1 where the primary outcome was the proportion of children with acute otitis media having reduction of pain scores with lignocaine compared with saline ear-drop groups at 10, 20 and 30 min from the baseline. The significant response in the lignocaine group could be attributed to skewed pain scores at …